ABSTRACT

In spite of the demonstrable value of Six Sigma and Lean

Manufacturing programs, there remains considerable

skepticism within the ranks of pharmaceutical engineers

and quality professionals about their validity. At the

same time, many process improvement professionals

attempting to use these tools and methods to reduce

variability and increase process efficiencies are surprised

by how often they are confronted with resistance centered

onoutmodednotions ofwhat itmeans tovalidate pharma-

ceutical processes. Often the very fact that the process has

been validated is used to justify resistance to process

improvement proposals.